Physician

John M. Henderson, D.O.

According to 2025 Medicare claims, John Henderson, D.O. (NPI: 1477597979) practices family practice in the Columbus, GA-AL market, with the plurality of this provider's patient population coming from Muscogee, GA. This provider's primary affiliated billing organization is JOHN M HENDERSON DO PC (NPI: 1699947176) and primary practice location at 31909-4196. Henderson is affiliated with the Aledade 154 FL GA MSSP Enhanced (ACO ID: A5357), participating under the MSSP model.

Henderson's data goes back to 2015 and runs through 2024. For example, in 2024, this provider had 638 traditional Medicare patients, billed 4,836 HCPCS/CPT codes, and received $349,745 in Medicare payments. The top billing code was G0439 (Annual wellness visit, includes a personalized prevention plan of service (pps), subsequent visit). Part D data shows 14,380 prescription claims across 674 beneficiaries totaling $1,261,573 in drug costs, led by Eliquis (Apixaban). DME data shows 1,112 claims. Open Payments data shows 38 records totaling $755. You can download detailed data with all billing codes (2015-2024). For more recent data, please contact us.

Over the past 10 years, this provider's Medicare Part B carrier billing has risen steadily, from $224,692 to $349,745. Similarly, Part D prescription costs have moved sharply higher in recent years, from $562,365 to $1,261,573. For DME billing, reported payments rose steadily, from $43,877 to $125,268.

Part B Carrier Billing Trend

Medicare payment trend, with N of patients and claim lines in the table.

Year	Patients	Clm Lines	Payment
2015	522	3,524	$224,692
2016	482	2,596	$158,310
2017	495	2,939	$174,374
2018	525	3,131	$186,637
2019	665	3,694	$238,761
2020	654	3,406	$219,950
2021	584	3,199	$208,910
2022	663	3,699	$229,709
2023	681	3,812	$253,110
2024	638	4,836	$349,745

Part D Events Trend

Drug cost trend, with N of patients and prescription claims in the table.

Year	Patients	Claims	Drug Cost
2015	468	8,695	$562,365
2016	464	8,129	$557,467
2017	447	7,446	$513,686
2018	522	7,868	$548,542
2019	567	11,749	$808,447
2020	600	12,665	$863,894
2021	652	14,454	$1,208,825
2022	640	15,253	$1,233,091
2023	677	14,691	$1,678,091
2024	674	14,380	$1,261,573

DME Billing Trend

Medicare payment trend, with N of patients and DME claim records in the table.

Year	Patients	Claims	Payment
2015	57	389	$37,032
2016	86	358	$26,275
2017	61	317	$22,889
2018	27	200	$4,554
2019	50	608	$35,536
2020	63	758	$68,452
2021	104	905	$94,886
2022	235	1,555	$177,044
2023	225	1,384	$172,511
2024	150	1,112	$150,586

* / # = suppressed by CMS; 0 = reported zero; N/R = not reported or blank.

Top 5 Part B carrier billing codes in 2024

By total payments.

Code	Description	Patients	Clm Lines	Total Payment
G0439	Annual wellness visit, includes a personalized prevention plan of service (pps), subsequent visit	222	222	$121
99316	Nursing facility discharge management, more than 30 minutes	162	206	$87
99214	Established patient office or other outpatient visit with moderate level of decision making, if using time, 30 minutes or more	329	793	$84
99308	Subsequent nursing facility care with straightforward level of medical decision making, per day, if using time, 20 minutes or more	197	1,475	$55
G0444	Annual depression screening, 5 to 15 minutes	214	214	$17

Top 5 Part D drugs in 2024

By total drug costs.

Drug	Generic	Claims	Total Day Supply	Total Drug Cost
Eliquis	Apixaban	366	7,701	$154,290
Xtandi	Enzalutamide	13	182	$92,428
Jardiance	Empagliflozin	103	4,123	$83,088
Farxiga	Dapagliflozin Propanediol	104	3,402	$64,848
Rybelsus	Semaglutide	34	1,980	$62,667

Top 5 DME services in 2024

By Total Medicare Payment Amount.

HCPCS Code	HCPCS Description	Supplier Rental Indicator	Total Supplier Beneficiaries	Total Supplier Claims	Total Medicare Payment Amount
A6010	Collagen based wound filler, dry form, sterile, per gram of collagen	N	17	41	$46,820
A4623	Tracheostomy, inner cannula	N	12	85	$16,793
A6021	Collagen dressing, sterile, size 16 sq. in. or less, each	N	11	24	$15,790
A6196	Alginate or other fiber gelling dressing, wound cover, sterile, pad size 16 sq. in. or less, each dressing	N	N/R	31	$8,170
B4154	Enteral formula, nutritionally complete, for special metabolic needs, excludes inherited disease of metabolism, includes altered composition of proteins, fats, carbohydrates, vitamins and/or minerals, may include fiber, administered through an enteral feeding tube, 100 calories = 1 unit	N	N/R	25	$7,698

Open Payments Summary in 2024

Category	Definition	Records	Total Reported Amount	Top Related Entity
General Payments	Reported payment or transfer-of-value amount.	38	$755	AstraZeneca Pharmaceuticals LP
Research Payments	Reported research-related payment or transfer-of-value amount.	0	$0	N/R
Ownership / Investment Interests	Reported value of ownership or investment interests.	0	$0	N/R

Explore More Providers

FAQ

What Medicare data is available for John M. Henderson, D.O.?

Tedicare shows public-source Medicare data for John M. Henderson, D.O. (NPI 1477597979), including provider identity, specialty, market context, Medicare Part B activity, Part D prescribing, DME records, Open Payments where available, billing organization details, and ACO affiliation signals where available. Profile data covers 2015-2024, with current attribution based on 2025 claims where available.

Does John M. Henderson, D.O. have ACO affiliation data?

John M. Henderson, D.O. is shown with ACO affiliation data for Aledade 154 FL GA MSSP Enhanced (MSSP, ACO ID A5357).

What billing organization is linked to John M. Henderson, D.O.?

John M. Henderson, D.O. is linked to JOHN M HENDERSON DO PC (billing NPI 1699947176) in the available physician profile data.

Does John M. Henderson, D.O. have Open Payments data?

John M. Henderson, D.O. has 38 connected Open Payments records in the available 2024 summary data.

Can I download physician-level Medicare data from Tedicare?

Yes. Tedicare provides sample physician export data and paid custom physician data exports for research, planning, outreach, and market analysis. Exports can include physician profile fields, market and specialty context, billing organization details, ACO affiliation signals where available, and Medicare utilization data.